ALKT vs DBD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

ALKT

43.5
AI Score
VS
DBD Wins

DBD

53.4
AI Score

Investment Advisor Scores

ALKT

44score
Recommendation
HOLD

DBD

53score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ALKT DBD Winner
Forward P/E 0 12.6422 Tie
PEG Ratio 0 0 Tie
Revenue Growth 19.4% 5.2% ALKT
Earnings Growth 0.0% -82.9% ALKT
Tradestie Score 43.5/100 53.4/100 DBD
Profit Margin -7.2% 2.0% DBD
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY DBD

Relative Price Performance (Last 90 Days)

ALKT 1M: +0.5% · 3M: -29.9% DBD 1M: -9.4% · 3M: -20.1%

Current Technical Phase

ALKT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.5 · Price: $14.16

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.9%), weak momentum, RSI 38

RSI (14): 38.3 · Price: $57.34

Fundamentals Snapshot

Metric ALKT DBD
Market Cap — —
Forward P/E 13.0 9.3
Trailing P/E — 28.5
Revenue (TTM) — —
Revenue Growth 0.2% 0.1%
Gross Margin 0.6% 0.3%
Operating Margin 0.0% 0.1%
EPS -0.35 2.11
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.